📖 Approx. 8 min ／ Updated 2026.08.09
In recent years, there has been an increase in M&A transactions involving dermatology clinics that combine general dermatology (insurance-based) with aesthetic dermatology (out-of-pocket services). While this model, which offers both a stable patient base from insurance services and high profitability from aesthetic services, is attractive, it requires unique due diligence, including asset valuation of medical equipment, compliance with medical advertising guidelines, and the succession of skills for physicians and staff. This article explains the key valuation points and legal/tax considerations for M&A of clinics with integrated aesthetic dermatology from an expert perspective.
Background: Why Clinics with Integrated Aesthetic Dermatology are Gaining Attention in the M&A Market
In the field of dermatology M&A, the demand for clinics that integrate aesthetic dermatology, not just general dermatology, is rapidly increasing. This trend is driven by changes in the medical management environment and the diversification of patient needs.
General dermatology clinics, as community-based primary care facilities, tend to secure a stable number of patients. However, due to repeated revisions in medical fee schedules and the promotion of regional medical care plans, there are cases where significant revenue growth solely from insurance-based services has limitations. On the other hand, aesthetic dermatology, being an out-of-pocket service, offers flexibility in pricing and the potential for high profitability by leveraging higher fees for self-pay treatments.
The strength lies in gaining the trust of local residents through general dermatology and then achieving cross-selling (referring patients) to aesthetic dermatology, triggered by visits for everyday skin concerns. This dual revenue structure is a significant incentive for medical corporations and individual physicians considering acquisition.
However, while integrated models offer high profitability, they are also susceptible to competitive risks and trend changes. Therefore, a comprehensive and objective analysis is necessary when calculating the transfer price (business valuation).
Differences in Business Valuation Between General and Aesthetic Dermatology and Due Diligence
In M&A business valuation, it is common to combine different valuation approaches for insurance-based and out-of-pocket services. Due diligence (detailed investigation) tailored to the specific revenue characteristics of each is essential.
For the valuation of the insurance-based dermatology department, emphasis is placed on the stability of patient numbers, repeat visit rates, and prescription patterns based on past medical claims data (recepts). Although there are seasonal fluctuations, demand in the region is relatively predictable, leading to a high evaluation of the certainty of future cash flows.
On the other hand, for the out-of-pocket aesthetic dermatology department, the key evaluation factors are the repeat visit rate for self-pay services, average customer spending, and reliance on web marketing and social media for patient acquisition. If the practice heavily depends on specific doctors or nurses, there is a risk of key personnel leaving after the succession. Therefore, not just past sales, but also the existence of a system that can maintain revenue as an organization is scrutinized.
| Evaluation Item | General Dermatology (Insurance-based) | Aesthetic Dermatology (Out-of-pocket) |
|---|---|---|
| Revenue Stability | High (Compliant with medical fee system) | Medium to Variable (Affected by trends/competition) |
| Profit Margin (Gross Margin) | Moderate (Affected by drug prices/material costs) | High (Depends on treatment/self-pay products) |
| Patient Acquisition Dependency | Location, regional reputation, physician’s expertise | Web advertising, social media, counselor skills |
| Main Risks at Transfer | Medical fee revisions, new competitor openings | Key person departure, medical incidents, advertising regulations |
*Valuation methods and weightings of indicators may vary by case, so assessment by a specialized institution is recommended.
Asset Valuation of Aesthetic Medical Equipment, Lease Contracts, and Corporate Asset Valuation
In the transfer of clinics with integrated aesthetic dermatology, the handling of aesthetic medical equipment (laser treatment devices, HIFU, phototherapy devices, etc.) is a significant practical issue. This is because many of these devices are expensive, and discrepancies often arise between their book value and market value (replacement cost or used market price).
While some equipment may have passed its statutory useful life and have a book value of 1 yen, if it is still operational and under a maintenance contract, its value may be recognized. Conversely, older models for which maintenance parts are no longer supplied may be significantly devalued.
Furthermore, if the equipment is leased, the transfer of the lease debt (change of name) is necessary. Since the leasing company’s approval is required, it is important to confirm the remaining lease period and debt balance early in the planning stage.
If the medical corporation is a “for-profit medical corporation with equity,” the valuation of the equity, including unrealized gains on fixed assets and retained earnings, will affect capital gains tax. For “non-profit medical corporations (without equity)” or “fund-based medical corporations,” legal arrangements regarding fund repayment procedures and the succession of contributors’ rights are essential.
Legal, Licensing, Tax Considerations, and Compliance Checks
The succession of clinics integrating aesthetic dermatology requires not only administrative procedures such as notifications to the medical board and public health centers but also strict legal and compliance checks specific to out-of-pocket services.
Particular attention must be paid to compliance with the “Medical Advertising Guidelines.” While websites and social media advertisements are used for patient acquisition in aesthetic dermatology, violations such as non-compliance with conditions for before-and-after photos, exaggerated advertising, and the posting of case photos that do not meet the requirements for lifting restrictions can lead to administrative guidance. To avoid the risk of the acquiring party receiving corrective orders after taking over, a legal review of existing promotional materials is mandatory.
- ☐ Schedule coordination for facility permits and change notifications to the public health center (e.g., change of administrator, change of medical specialty)
- ☐ Succession or re-application for designation as a medical insurance provider (in case of business transfer)
- ☐ Prior verification of websites, social media, and flyers against Medical Advertising Guidelines
- ☐ Status of preparation of informed consent forms and explanation documents for out-of-pocket services
- ☐ Confirmation of usage and storage/management of unapproved imported drugs, pharmaceuticals, and medical devices
- ☐ Confirmation of procedures for notification of executive changes and convocation of general meetings to the prefectural government for medical corporations
From a tax perspective, pre-calculation of the conditions for exemption from business tax related to the continuation of medical practice, and the differences in capital gains tax/corporate tax depending on the transferor (business transfer by an individual proprietor vs. transfer of equity/change of executives of a medical corporation), will lead to a smooth transaction conclusion.
Steps for Successful Business Succession in M&A of Dermatology Clinics with Integrated Aesthetics
The standard process from considering a transfer to closing (contract signing and handover) is as follows. The transfer of know-how for the aesthetic services department and the continued employment of staff are particularly key to success.
- Initial Consultation and Signing of Non-Disclosure Agreement (NDA)
Understand the overview of the transaction and organize the desired terms for sale/purchase. - Information Gathering and Business Valuation
Calculate an estimated transfer price based on financial statements, claims data, sales by aesthetic treatment, equipment lists, etc. - Matching and Top-Level Meeting
Discuss management philosophy, treatment policies, and post-succession plans between the seller and potential buyer. - Signing of Letter of Intent (LOI) and Acquisition Audit (Due Diligence)
After agreeing on the price and key terms, conduct financial, legal, and medical due diligence by certified public accountants, lawyers, etc. - Signing of Final Transfer Agreement (DA) and Licensing Procedures/Handover
In parallel with facility notification procedures to administrative bodies, transfer medical record data and treatment protocols, and communicate with staff.
While insurance-based general dermatology can transition smoothly with the transfer of medical record information, aesthetic dermatology requires the transmission of un-manualized know-how, such as “counselor service flows,” “nursing staff treatment techniques,” and “procurement routes for medications.” It is common to establish a support period where the former director remains as an honorary director or part-time physician for a certain period after the transfer.
Key Points for Successful Third-Party Succession (M&A)
To ensure the success of a clinic succession with integrated aesthetic dermatology, it is necessary to comprehensively assess whether the medical system can be maintained in line with regional medical needs, rather than just evaluating numerical sales and profits.
For the seller, the goal is to secure a fair founder’s profit while protecting the clinic’s philosophy and the employment of staff who have been nurtured over time. For the buyer, a strategy that leverages the growth potential of aesthetic dermatology to achieve a return on investment, while gaining a solid foundation in insurance-based services, is crucial.
Compared to M&A of general companies, medical practice succession requires specialized knowledge due to regulations such as the Medical Care Act, dealing with public health center administration, and consideration for the unique human relationships within a medical setting. When considering a transfer or acquisition, it is advisable to proceed with meticulous planning under the guidance of M&A specialists familiar with the medical industry.
At M&A Medical, we provide dedicated advisors with specialized knowledge and extensive experience in M&A and business succession for medical institutions, including dermatology and aesthetic dermatology. We offer thorough consultations regarding the valuation of your clinic’s assets, proposals for succession schemes, and concerns about finding a successor. Please feel free to contact us.
Consultations on Medical Succession with M&A Medical
M&A Medical is a specialized M&A and business succession support service for medical institutions. As a certified M&A support institution by the Small and Medium Enterprise Agency, we support everything from the transfer of clinics and medical corporations struggling with a lack of successors to strategic acquisitions on a success-fee basis.
- Initial consultation and preliminary appraisal are free
- No upfront fees or monthly charges (success fee only)
- Strict confidentiality (proceeds under NDA)
- Support available nationwide across all 47 prefectures and all medical specialties
Whether you just want to know the market price, have no successor, or are considering joining a group, it’s best to consult with us early in the consideration phase.